GMED
$88.16
Globus Medical, Inc.
Intraday
Recent News
1 Cash-Producing Stock to Target This Week and 2 That Underwhelm
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Should You Continue to Hold Bio-Techne Stock in Your Portfolio?
TECH expands via acquisitions and global growth, but biotech funding softness, U.S. academic spending pressure and competition cloud near-term outlook.
Is Resmed Stock the Right Pick for Your Portfolio Now?
RMD expands mask and device sales while maintaining strong liquidity, but macro and competitive pressures loom.
Should You Continue to Hold Integra Stock in Your Portfolio Now?
IART faces macro headwinds and tight liquidity, but strong demand in its Codman Specialty Surgical unit and expanding international launches could support growth.
Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now
New pump launches, CGM integrations and strong solvency support Tandem Diabetes' growth outlook, though intense competition and macro headwinds remain risks.